Healthcare Administration & Management · Independent exam preparation
CMC Adult Cardiac Medicine: Clinical Judgment Guide Study Guide
Develop adult cardiac nursing judgment through mechanisms, discriminating clinical findings, treatment safety checks and interpretation of monitoring.
By CertMedbry · Updated 3 November 2026
Connect ischemia, congestion, impaired perfusion and organ dysfunction with the interventions that address their mechanisms. Use the clinical concepts, original practice cases and flashcards to explain why a finding changes assessment or treatment.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which examination version does this guide follow?
This guide follows the August 2026 CMC Exam Handbook test plan applicable to examinations taken through November 18, 2026. AACN's revised CMC examination begins November 19, 2026. Candidates testing from that date must use the revised official outline.
What is the examination format?
The applicable handbook specifies 90 multiple-choice items in two hours. Seventy-five items are scored; 15 unscored items collect statistical information for future examinations. The examination addresses adult patients, and all examination content concerns clinical judgment.
What testing options does the handbook describe?
The handbook describes computer-based testing at PSI testing centers and through live remote proctoring. It also describes arrangements for paper-and-pencil examinations and testing outside the United States. These independent practice questions are learning exercises rather than a simulation of the examination's scoring process.
How do the official domains relate to this guide?
The applicable weights are Cardiovascular Conditions 23%, Non-Cardiovascular Conditions 23%, Therapeutic Interventions 39%, and Monitoring and Diagnostics 16%. AACN explains that rounding produces a 101% total. This guide contains 14, 14, 23 and nine concepts in those domains, respectively. The questions contain four, four, nine and three items, respectively; the flashcards contain five, four, eight and three. These selective allocations do not replace the complete official outline.
Who awards CMC, and who is eligible?
AACN Certification Corporation awards CMC as an adult cardiac medicine nursing subspecialty. Eligibility requires current unencumbered U.S. RN or APRN licensure, an acceptable current clinical nursing specialty certification and qualifying practice hours. The handbook provides two-year and five-year practice options for the same credential. CMC does not confer nurse practitioner licensure.
How does CMC differ from CSC?
CMC addresses direct care of acutely or critically ill adult cardiac medicine patients. CSC addresses direct care of acutely or critically ill adults during the first 48 hours after cardiac surgery. They are separate nursing subspecialty certifications with their own eligibility requirements and examination outlines.
What passing standard does AACN describe?
AACN describes a criterion-referenced passing standard established through a modified Angoff process with subject matter experts and psychometric guidance. The supplied handbook does not state a numerical passing score. Performance on this short practice set should identify study needs rather than predict certification success.
These independent educational materials are not official AACN examination items or endorsed preparation materials. The 60-concept guide is selective. The official AACN CMC test plan defines the complete examination scope.
Outline used: August 2026 CMC Exam Handbook, adult cardiac medicine subspecialty. This guide follows the test plan applicable through November 18, 2026, which is current on October 18, 2026. AACN's revised examination takes effect November 19, 2026.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Cardiovascular Conditions23%
1.What distinguishes myocardial injury from myocardial infarction?
Cardiac troponin above the assay's sex-specific 99th-percentile upper reference limit establishes myocardial injury. A rise or fall supports an acute process. Infarction additionally requires evidence of acute myocardial ischemia, such as ischemic symptoms, new ischemic ECG changes or compatible imaging. Women commonly have lower reference limits; a single pooled threshold can therefore underrecognize injury in women. Use the particular assay's validated limits. [AHA definition summary](https://professional.heart.org/en/science-news/fifth-universal-definition-of-myocardial-infarction-2026/top-things-to-know).
Apply it
A woman with pneumonia has rising troponin exceeding the assay's female reference limit but no ischemic symptoms, ischemic ECG changes or new ischemic imaging findings. Recognize acute myocardial injury without automatically diagnosing infarction.
Common pitfall: A changing troponin establishes acuity rather than coronary thrombosis. One early normal result cannot exclude an evolving infarction in a compatible presentation.
2.What suggests effusive-constrictive physiology after pericardial drainage?
Effusive-constrictive physiology combines a pericardial effusion with persistent restriction of cardiac filling after drainage. It is suggested when right atrial pressure fails to fall by 50% or below 10 mm Hg after pericardiocentesis. Removing fluid relieves the pressure attributable to the effusion, but a constraining visceral pericardium can continue to impair filling. Pressure measurements therefore help explain persistent venous congestion after apparently successful drainage.
Apply it
After drainage, right atrial pressure falls from 20 to 15 mm Hg and jugular venous distention persists. The pressure remains above 10 mm Hg and has fallen by less than half, supporting assessment for effusive-constrictive physiology.
Common pitfall: Persistent elevated right atrial pressure requires clinical interpretation because right ventricular disease or other causes of venous hypertension can also contribute.
2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
3.How does ejection fraction classify heart failure?
HFrEF has left ventricular ejection fraction of 40% or less; HFmrEF spans 41–49%; HFpEF has ejection fraction of at least 50%. For HFmrEF and HFpEF, supporting evidence of increased filling pressures helps establish the syndrome. A preserved fraction can coexist with impaired relaxation, pulmonary congestion and severe functional limitation. Classification informs treatment, while congestion and perfusion determine immediate bedside priorities.
Apply it
A patient has dyspnea, pulmonary congestion, elevated natriuretic peptides and ejection fraction of 58%. Evaluate evidence of increased filling pressures rather than excluding heart failure because systolic ejection fraction is preserved.
Common pitfall: A normal ejection fraction does not establish normal cardiac filling. Dyspnea alone also does not establish HFpEF without supporting cardiac evidence.
4.How do congestion and hypoperfusion differ in acute heart failure?
Congestion reflects elevated filling pressures and fluid redistribution or accumulation. Orthopnea, pulmonary crackles, elevated jugular venous pressure and edema support this pattern. Hypoperfusion reflects insufficient tissue blood flow and may produce cool extremities, altered mentation or reduced urine output. The two processes can occur separately or together. Systemic blood pressure alone does not establish whether tissue perfusion is adequate.
Apply it
A patient with pulmonary edema becomes confused, develops cool hands and produces little urine despite a systolic pressure of 108 mm Hg. Recognize combined congestion and hypoperfusion and reassess for evolving circulatory failure.
Common pitfall: Edema does not prove adequate forward flow. Fluid administration based solely on oliguria can worsen congestion, while diuretic escalation without perfusion assessment can miss deterioration.
5.Why can a relatively small pericardial effusion cause tamponade?
Tamponade develops when pericardial pressure impairs cardiac filling and reduces output. The rate of fluid accumulation and the pericardium's ability to stretch matter more than volume alone. Rapid accumulation can produce severe compromise before an effusion becomes large. Hypotension, elevated jugular venous pressure, tachycardia and pulsus paradoxus are useful clues, but an incomplete set of classic findings does not exclude tamponade.
Apply it
Following an invasive cardiac procedure, a patient develops hypotension and rising jugular venous pressure. Echocardiography shows a modest new effusion with chamber collapse. Recognize urgent tamponade physiology despite the limited fluid volume.
Common pitfall: A large chronic effusion may be tolerated better than a rapidly accumulating smaller one. Waiting for every classic physical sign can delay recognition of obstructive shock.
2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
6.Which findings suggest an acute valvular emergency after infarction?
Papillary muscle rupture can produce acute severe mitral regurgitation within days of infarction. Blood regurgitates into a relatively noncompliant left atrium, abruptly raising pulmonary venous pressure while reducing forward output. Sudden pulmonary edema and shock require urgent echocardiography and surgical evaluation. The murmur can be soft or absent because ventricular and atrial pressures rapidly equalize. [AHA mechanical-complications statement](https://pmc.ncbi.nlm.nih.gov/articles/PMC9364424/).
Apply it
Four days after an inferior infarction, a patient develops abrupt hypoxemia, pulmonary edema and hypotension with only a faint systolic murmur. Escalate immediately for echocardiographic assessment of acute mitral regurgitation and other mechanical complications.
Common pitfall: Murmur loudness does not reliably measure acute regurgitation severity. Preserved or apparently vigorous left ventricular contraction does not establish adequate forward output.
7.When should myocarditis enter the differential diagnosis?
Myocarditis can present with chest pain, new heart failure, ventricular arrhythmias or conduction disease, sometimes following an infectious illness. Inflammation injures cardiomyocytes and can impair contractility or create an arrhythmogenic substrate. Hemodynamic instability, sustained ventricular arrhythmias or advanced conduction block identify a higher-risk presentation. Cardiac MRI assesses edema and injury patterns, including fibrosis or scar, and adds tissue information beyond ejection fraction. Ischemic and nonischemic patterns require integration with the coronary assessment.
Apply it
A previously well adult develops new ventricular dysfunction and ventricular tachycardia after a febrile illness. Include myocarditis in the differential and recognize both findings as reasons for monitored specialist assessment.
Common pitfall: A preceding viral illness provides context rather than proof. Preserved ejection fraction does not exclude myocarditis, and MRI should not delay stabilization of an unstable patient.
2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
8.How do you determine whether tachycardia is causing instability?
Assess whether a persistent tachyarrhythmia is producing hypotension, acute altered mental status, shock, ischemic discomfort or acute heart failure. A rapid rate can instead be a compensatory response to hypoxemia, hemorrhage or another illness. Relate rhythm onset to perfusion changes and examine the rhythm mechanism. Cardioversion treats an unstable arrhythmia, whereas sinus tachycardia usually requires correction of its physiological cause.
Apply it
A patient abruptly develops regular wide-complex tachycardia followed immediately by hypotension and confusion. The temporal relationship supports arrhythmia-driven instability and the need for urgent electrical treatment.
Common pitfall: Heart rate alone does not establish an indication for cardioversion. Shocking compensatory sinus tachycardia fails to address the underlying problem and can distract from necessary resuscitation.
9.What distinguishes torsades de pointes from other polymorphic VT?
Torsades de pointes is polymorphic ventricular tachycardia associated with a prolonged preceding QT interval. QT-prolonging medications, hypokalemia, hypomagnesemia and bradycardia can increase susceptibility. Polymorphic VT with a normal QT often has a different mechanism, including acute ischemia. This distinction guides recurrence prevention. Sustained polymorphic VT requires immediate unsynchronized shock because its changing complexes prevent reliable synchronization.
Apply it
A patient taking a QT-prolonging medication develops pause-associated polymorphic VT after potassium falls. Review the preceding QT, remove contributing exposure and correct electrolytes while preparing immediate shock for a sustained episode.
Common pitfall: Twisting QRS morphology alone does not establish torsades. Magnesium does not replace immediate electrical treatment of sustained polymorphic VT or evaluation for an ischemic mechanism.
10.What distinguishes hypertensive emergency from severe hypertension without acute organ injury?
Hypertensive emergency combines severe blood-pressure elevation, commonly systolic pressure above 180 mm Hg or diastolic pressure above 120 mm Hg, with acute target-organ injury. Examples include pulmonary edema, encephalopathy, acute coronary ischemia, acute kidney injury and acute aortic injury. The pressure value alone does not establish an emergency. Acute injury requires urgent, condition-specific treatment with intensive monitoring and consideration of parenteral therapy. For nonpregnant, nonstroke emergencies without a compelling condition, the 2025 guideline permits oral or parenteral treatment: reduce systolic pressure by no more than 25% during the first hour, then, if stable, below 160/100 mm Hg over the next 2–6 hours, followed by cautious further reduction. This schedule does not replace the separate treatment strategies for acute aortic syndromes or stroke. [2025 AHA/ACC blood-pressure guideline, section 6.2](https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000001356).
Apply it
Blood pressure of 218/126 mm Hg accompanied by new pulmonary edema and respiratory distress indicates hypertensive emergency because acute cardiac and respiratory injury is present. Anticipate urgent intravenous blood-pressure treatment addressing afterload, together with respiratory support and close reassessment. In contrast, the same pressure without acute organ injury does not by itself justify emergency intravenous treatment. Assess symptoms, examination findings and organ-specific testing before assigning the emergency classification.
Common pitfall: Avoid immediate normalization or a universal intravenous-treatment rule. Excessive pressure reduction can compromise organ perfusion. Acute aortic syndrome requires prompt anti-impulse treatment: intravenous beta blockade before adding a vasodilator when needed, targeting heart rate 60–80/min and systolic pressure below 120 mm Hg or the lowest pressure preserving organ perfusion. Stroke management follows separate targets determined by stroke subtype and reperfusion treatment eligibility; do not automatically apply the general first-hour reduction schedule.
cmcexamhandbook.pdf · 2022 ACC/AHA Aortic Disease Guideline Slide Set
11.How do anatomy and complications determine the dissection pathway?
Stanford type A dissection involves the ascending aorta and requires immediate surgical evaluation because rupture, tamponade, acute aortic regurgitation and coronary compromise can develop rapidly. Type B spares the ascending aorta; uncomplicated acute cases initially receive medical therapy and surveillance. Rupture, malperfusion, extension, progressive enlargement, intractable pain or uncontrolled hypertension can require intervention. Abdominal pain, oliguria, limb ischemia and neurological deficits can reveal branch-vessel malperfusion despite improved systemic pressure.
Apply it
A patient receiving medical treatment for type B dissection develops abdominal pain and decreasing urine output. Reassess urgently for malperfusion and communicate the change as a possible indication for intervention.
Common pitfall: Pain location cannot reliably classify a dissection. Controlled systemic pressure does not prove adequate branch-vessel perfusion or exclude evolving complications.
2022 ACC/AHA Aortic Disease Guideline Key Perspectives: Part 2
12.Which syncope findings suggest a dangerous cardiac cause?
Syncope is transient loss of consciousness from cerebral hypoperfusion. Initial assessment includes history, examination, blood pressure and heart rate, and a resting 12-lead ECG. Conduction disease, ventricular arrhythmia, ischemia, severe aortic stenosis or significant ventricular dysfunction raises concern for a serious cardiac cause and supports hospital evaluation. A recognizable reflex trigger does not outweigh a documented dangerous rhythm. [ACC/AHA/HRS syncope guideline summary](https://professional.heart.org/en/science-news/2017-acc-aha-hrs-guideline-for-the-evaluation-and-management-of-patients-with-syncope/top-things-to-know).
Apply it
After abrupt loss of consciousness, a patient has intermittent complete AV block on telemetry. Maintain monitored care, assess perfusion and prepare treatment of symptomatic conduction disease.
Common pitfall: Rapid recovery does not establish benign syncope. Routine broad testing should not replace the focused history, examination and ECG that identify a serious underlying condition.
cmcexamhandbook.pdf · AHA 2025 Guidelines, Part 9: Adult Advanced Life Support
13.Which findings identify an immediately threatened ischemic limb?
Acute limb ischemia requires assessment of pain, temperature, sensory function, motor function and Doppler signals. Sensory loss extending beyond the toes and new weakness suggest an immediately threatened but potentially salvageable limb. Profound anesthesia and paralysis raise concern for irreversible injury. Viability determines urgency and treatment options. Systemic unfractionated heparin is generally administered promptly unless contraindicated to limit thrombus propagation while revascularization assessment proceeds.
Apply it
A patient has sudden leg pain, absent arterial Doppler signals, sensory loss beyond the toes and new ankle weakness. Activate immediate vascular evaluation and anticipate anticoagulation after contraindication review.
Common pitfall: Pulselessness does not automatically establish irreversible injury. Heparin limits propagation but does not replace urgent restoration of flow to threatened tissue; suspected HIT changes anticoagulant selection.
14.Why can a reperfused limb deteriorate despite restored pulses?
Reperfusion can cause tissue edema, compartment pressure elevation and systemic release of potassium and muscle breakdown products. Compartment syndrome compromises microvascular perfusion despite restored flow through the treated artery. Escalating pain, pain with passive movement, tense swelling and neurological changes require urgent assessment. Systemic consequences can include hyperkalemia and kidney injury, making electrolyte and renal surveillance important after revascularization.
Apply it
Following leg revascularization, a patient develops tense calf swelling and severe pain with passive toe movement despite a detectable pedal pulse. Suspect compartment syndrome and seek immediate surgical assessment.
Common pitfall: Restored arterial pulses do not exclude impaired tissue perfusion within a pressurized compartment. Treating all postprocedure pain as expected can delay intervention while nerves and muscle are injured.
Non-Cardiovascular Conditions23%
15.How does ARDS differ from hydrostatic pulmonary edema?
ARDS involves inflammatory alveolar-capillary injury, increased permeability and impaired gas exchange. Hydrostatic pulmonary edema primarily reflects elevated pulmonary vascular pressure, often from cardiac dysfunction. Both processes can produce bilateral opacities and hypoxemia, and both may coexist. Assess the precipitating illness, cardiac findings and imaging rather than assigning a mechanism from crackles alone. Recognition of inflammatory lung injury supports ventilation that limits additional pressure and volume injury.
Apply it
A patient with pneumonia develops severe hypoxemia and bilateral opacities that cardiac dysfunction does not adequately explain. Consider ARDS and review tidal volume and plateau pressure for lung protection.
Common pitfall: Bilateral opacities do not automatically establish heart failure. An ARDS diagnosis also does not exclude a simultaneous contribution from congestion or cardiac dysfunction.
ATS/ESICM/SCCM Mechanical Ventilation in Adult ARDS Guideline — 2017
16.Why can pulmonary embolism produce obstructive shock?
Pulmonary vascular obstruction increases right ventricular afterload. Severe obstruction can cause right ventricular dilation, reduced forward flow and impaired left ventricular filling, producing obstructive shock. Abrupt dyspnea, hypoxemia and hypotension warrant consideration of pulmonary embolism in the appropriate context. Right ventricular abnormalities on bedside ultrasound can support concern but are not sufficiently specific to establish the diagnosis independently.
Apply it
An immobilized patient develops abrupt dyspnea, hypotension and a newly dilated right ventricle. Consider pulmonary vascular obstruction while supporting circulation and arranging appropriate diagnostic evaluation.
Common pitfall: Right ventricular dilation has other causes. During cardiac arrest, ultrasound should neither become a stand-alone diagnosis nor produce prolonged interruptions in chest compressions while clinicians investigate the mechanism.
17.What establishes DKA, and which findings govern safe treatment and resolution?
DKA requires glucose at least 200 mg/dL or prior diabetes irrespective of glucose; beta-hydroxybutyrate at least 3.0 mmol/L or urine ketones at least 2+; and pH below 7.3 or bicarbonate below 18 mmol/L. Prior diabetes permits recognition of euglycemic DKA, including during SGLT2 inhibitor exposure. Potassium below 3.5 mmol/L requires replacement and postponement of insulin until potassium exceeds 3.5. Resolution requires plasma ketones below 0.6 mmol/L and pH at least 7.3 or bicarbonate at least 18; glucose should ideally be below 200 mg/dL.
Apply it
A patient with diabetes has glucose 238 mg/dL, beta-hydroxybutyrate 4.6 mmol/L, bicarbonate 14 mmol/L and potassium 3.2 mmol/L. Recognize DKA while prioritizing fluids and potassium before insulin.
Common pitfall: Glucose normalization alone does not establish resolution. Urine ketones can remain positive as beta-hydroxybutyrate converts to acetoacetate; treatment-related hyperchloremic acidosis can also make the anion gap misleading.
Hyperglycaemic Crises in Adults With Diabetes: A Consensus Report — 2024
18.How do HHS diagnostic criteria differ from its insulin-treatment branches?
HHS requires glucose at least 600 mg/dL; effective osmolality above 300 mOsm/kg or total osmolality above 320; beta-hydroxybutyrate below 3.0 mmol/L or urine ketones below 2+; and pH at least 7.3 with bicarbonate at least 15 mmol/L. For HHS without acidosis, including bicarbonate at least 18, IV insulin is 0.05 units/kg/hour. Significant ketosis or acidosis—beta-hydroxybutyrate at least 3.0, urine ketones at least 2+, pH below 7.3 or bicarbonate below 18—directs the mixed DKA/HHS pathway at 0.1 units/kg/hour after potassium safety requirements are satisfied.
Apply it
Glucose 780 mg/dL, effective osmolality 324, beta-hydroxybutyrate 1.2, pH 7.32 and bicarbonate 16 satisfy HHS diagnostic components but direct the mixed DKA/HHS insulin-treatment pathway. Potassium must exceed 3.5 mmol/L before insulin.
Common pitfall: Do not replace the diagnostic bicarbonate threshold of 15 with the treatment threshold of 18. Proposed resolution includes osmolality below 300, urine output above 0.5 mL/kg/hour, improved cognition and glucose below 250 mg/dL; glucose improvement alone is insufficient.
Hyperglycaemic Crises in Adults With Diabetes: A Consensus Report — 2024
19.Which immediate decisions matter when a cardiac patient develops a focal neurological deficit?
New aphasia, unilateral weakness or other abrupt focal deficits require immediate stroke activation. Establish last-known-well time, assess glucose and arrange emergency brain imaging to distinguish hemorrhage from ischemia. Record anticoagulant exposure because it affects reperfusion eligibility. Eligible adults with disabling ischemic deficits can receive alteplase or tenecteplase within 4.5 hours; selected patients qualify for later treatment using imaging criteria. Large-vessel occlusion also requires thrombectomy assessment. [2026 AHA/ASA stroke guideline](https://www.ahajournals.org/doi/10.1161/STR.0000000000000513).
Apply it
A patient with atrial fibrillation develops aphasia and right arm weakness. Activate the stroke response, document last-known-well time and the last anticoagulant dose, check glucose and expedite imaging.
Common pitfall: Do not assume an embolic mechanism before excluding hemorrhage. A low neurological severity score does not make disabling aphasia unimportant or remove the need for urgent reperfusion assessment.
20.How does alcohol withdrawal change assessment of tachycardia and agitation?
After a substantial reduction in sustained alcohol intake, tremor, diaphoresis, agitation, tachycardia and hypertension suggest withdrawal; seizures or delirium identify complicated withdrawal. Ask about the last drink and previous withdrawal seizures or delirium while evaluating competing causes such as hypoglycemia, hypoxemia or infection. Benzodiazepines are first-line treatment for moderate or severe withdrawal and reduce seizure and delirium risk. Monitor sedation, ventilation and circulation during treatment. [ASAM withdrawal guideline](https://www.asam.org/docs/default-source/quality-science/the_asam_clinical_practice_guideline_on_alcohol-1.pdf).
Apply it
A hospitalized patient who stopped daily heavy drinking develops tremor, sweating and escalating agitation. Assess withdrawal severity and prior complications, initiate the prescribed withdrawal pathway and maintain cardiac and respiratory surveillance.
Common pitfall: Beta blockade can blunt tachycardia without preventing withdrawal seizures or delirium. Symptom scales requiring reliable patient responses are unsuitable for a delirious or noncommunicative patient.
21.Which platelet pattern raises concern for HIT?
Immune HIT is a prothrombotic reaction in which antibodies against platelet factor 4–heparin complexes activate platelets. Assess the percentage platelet fall, its timing, thrombosis and competing causes using the 4Ts framework. A substantial relative decline may be concerning even if the absolute count remains near the reference range. New thrombosis during a compatible platelet decline increases concern rather than indicating protection from clotting.
Apply it
Six days after heparin starts, platelets fall from 310 to 145 × 10^9/L and a new venous thrombosis appears. Recognize the substantial relative decline and compatible timing and promptly calculate HIT probability.
Common pitfall: Waiting for profound thrombocytopenia can miss HIT. A falling platelet count does not make ongoing heparin exposure safe when the syndrome is activating thrombosis.
22.How does a low 4Ts score change HIT evaluation?
A reliably calculated 4Ts score of 0–3 indicates low clinical probability of HIT. ASH recommends against routine HIT testing or empiric HIT treatment in that setting. Unnecessary antibody testing can produce misleading positive results and expose patients to alternative anticoagulation and bleeding risk. The score requires accurate exposure history, platelet trends, thrombosis assessment and competing explanations. Missing information can undermine an apparently low result.
Apply it
A patient has a documented score of two based on complete information and a clear alternative cause of thrombocytopenia. Avoid reflex HIT testing while continuing clinical surveillance.
Common pitfall: A low score is not reliable when key timing or platelet information is missing. Recalculate when the clinical picture changes instead of treating the original score as permanent.
23.Why does anemia matter during acute coronary syndrome?
Anemia lowers arterial oxygen content and can worsen myocardial oxygen supply-demand imbalance even when saturation is normal. The 2025 ACS guideline states that transfusion to maintain hemoglobin at 10 g/dL may be reasonable in patients with ACS and acute or chronic anemia who are not actively bleeding. This conditional recommendation requires consideration of ischemia, hemoglobin trajectory, congestion and transfusion risks. [AHA ACS guideline summary](https://professional.heart.org/en/science-news/2025-guideline-for-the-management-of-patients-with-acute-coronary-syndromes/top-things-to-know).
Apply it
A patient with ACS has continuing ischemic symptoms and hemoglobin 8.4 g/dL without active bleeding. Recognize reduced oxygen-carrying capacity and anticipate an individualized transfusion discussion that includes volume tolerance.
Common pitfall: Normal oxygen saturation cannot exclude inadequate oxygen delivery from anemia. A conditional ACS recommendation is not a universal transfusion threshold for all clinical settings.
24.What changes meet established AKI criteria?
Published KDIGO criteria identify AKI with a creatinine increase of at least 0.3 mg/dL within 48 hours, an increase to at least 1.5 times baseline within seven days, or urine output below 0.5 mL/kg/hour for six hours. Either the creatinine or urine-output criterion can establish AKI. Timing and baseline matter because a value within the laboratory reference range may still represent acute injury.
Apply it
A 70-kg patient produces 180 mL over six hours. Output is approximately 0.43 mL/kg/hour, meeting the urine-output criterion before a diagnostic creatinine rise is documented.
Common pitfall: Waiting for creatinine to exceed the laboratory reference range can delay recognition. A chronic elevation alone also does not establish a qualifying acute change.
KDIGO Clinical Practice Guideline for Acute Kidney Injury — 2012
25.How can congestion contribute to kidney dysfunction?
Kidney function depends on arterial inflow and the pressure opposing venous drainage. In heart failure, elevated venous pressure can impair filtration even when systemic blood pressure appears adequate. Reduced forward flow, medications and intrinsic kidney injury can also contribute. Interpret creatinine changes alongside congestion, perfusion, urine output and treatment response. A rising creatinine does not automatically mean that the patient needs fluid or that all decongestion must stop.
Apply it
A patient with elevated jugular venous pressure, edema and preserved blood pressure develops worsening kidney function. Include venous congestion in the assessment rather than assuming dehydration from creatinine alone.
Common pitfall: Empiric fluid can worsen congestive physiology. Attributing every renal change to congestion can conversely miss hypotension, obstruction, nephrotoxic exposure or intrinsic kidney disease.
2022 AHA/ACC/HFSA Heart Failure Guideline Slide Set · KDIGO Clinical Practice Guideline for Acute Kidney Injury — 2012
26.How do stabilization, shifting and removal differ in hyperkalemia treatment?
Intravenous calcium stabilizes the myocardium when hyperkalemia produces concerning ECG changes, but it does not lower potassium. Insulin, with glucose when appropriate, shifts potassium intracellularly and requires glucose monitoring for hypoglycemia. Redistribution is temporary, so repeat potassium testing detects response and rebound. Dialysis, potassium-binding agents and effective renal excretion remove potassium from the body. Severe refractory hyperkalemia warrants urgent assessment for dialysis.
Apply it
A patient with AKI has potassium 7.1 mmol/L and widening QRS complexes. Prepare immediate calcium, potassium-shifting treatment and urgent assessment for definitive removal while maintaining continuous monitoring.
Common pitfall: A normal ECG does not exclude dangerous hyperkalemia. Neither calcium nor insulin eliminates the excess potassium burden, even when electrical or biochemical findings initially improve.
27.How do you recognize AKI superimposed on CKD?
CKD describes kidney structural or functional abnormalities persisting for more than three months. AKI describes a qualifying acute creatinine change or urine-output reduction and can occur on top of CKD. Compare current findings with prior measurements and assess timing, circulation, obstruction and nephrotoxic exposure. KDIGO recommends reassessment three months after AKI for resolution, new CKD or worsening pre-existing CKD.
Apply it
A patient with established CKD has creatinine rise from 1.8 to 2.3 mg/dL within 48 hours. The 0.5-mg/dL increase meets AKI criteria despite an already abnormal baseline.
Common pitfall: One abnormal creatinine cannot establish chronicity. An existing CKD diagnosis must also not obscure a new acute process that may require treatment of reversible contributors.
KDIGO Clinical Practice Guideline for Acute Kidney Injury — 2012
28.How can psychosocial assessment prevent recurrent diabetic crises?
Insulin omission can reflect cost, inadequate supplies, depression, diabetes distress, substance use or misunderstanding. Prevention requires identifying the particular barrier and matching support to it. Ask directly and without blame about access, dosing, sick-day management and emotional health. A practical discharge plan verifies that the patient can obtain insulin, explain actions during illness and identify how to reach help before ketosis progresses.
Apply it
A patient with recurrent DKA explains that insulin was rationed after prescription coverage ended. Prioritize a dependable supply plan and follow-up alongside education, then verify access before discharge.
Common pitfall: Repeating generic adherence advice does not solve an affordability problem. Blaming the patient can conceal treatable distress or practical barriers and make an effective prevention plan less likely.
Hyperglycaemic Crises in Adults With Diabetes: A Consensus Report — 2024
Therapeutic Interventions39%
29.Why is radial access preferred for many ACS PCI procedures?
For ACS patients undergoing PCI, the 2025 guideline favors radial over femoral access to reduce bleeding, vascular complications and mortality. Access selection still depends on procedural requirements and patient anatomy. After radial access, assess the puncture site, forearm swelling, hand perfusion and symptoms of bleeding or compression. A preferred access route reduces risk but does not remove the need for systematic postprocedure surveillance.
Apply it
A patient returns from radial PCI with increasing forearm swelling and pain. Assess promptly for an access complication rather than assuming the radial approach makes significant bleeding impossible.
Common pitfall: Radial access does not eliminate hemorrhage or hand-perfusion concerns. Procedural success and a small visible puncture do not establish that underlying tissues are free of an evolving hematoma.
ACC, AHA Issue New Acute Coronary Syndromes Guideline — 2025
30.What is the priority in infarction with cardiogenic shock?
When acute myocardial infarction causes cardiogenic shock, prompt revascularization addresses the ischemic source of pump failure. Vasoactive or mechanical support can stabilize circulation but does not replace restoration of coronary perfusion. Assess mentation, urine output, skin perfusion and hemodynamic trends while preparing definitive treatment. A transient rise in blood pressure after support does not establish that the underlying coronary problem has resolved.
Apply it
A patient with acute infarction has cold extremities, oliguria and hypotension. Support circulation while expediting emergency coronary evaluation and revascularization rather than waiting for organ function to normalize.
Common pitfall: Improved pressure after vasoactive therapy does not prove restored myocardial perfusion. Stabilization should facilitate definitive treatment rather than become a reason to postpone it.
ACC, AHA Issue New Acute Coronary Syndromes Guideline — 2025
31.When is pericardial drainage urgent, and when is surgery recommended?
Hemodynamically significant tamponade requires urgent drainage to relieve impaired filling and restore output. Method selection depends on stability, cause and anatomy. Purulent pericardial disease requires antimicrobial treatment and complete drainage; surgical drainage helps achieve source control and reduce complications, including constriction. In suspected malignant disease, cytological examination of pericardial fluid can help confirm neoplastic involvement. Drainage therefore serves both physiological and diagnostic purposes.
Apply it
A patient with tamponade and suspected bacterial pericardial infection requires urgent drainage and antimicrobial treatment. Anticipate surgical assessment for complete drainage rather than treating limited initial aspiration as adequate source control.
Common pitfall: Pressure support cannot remove tamponade's mechanical obstruction. Temporary hemodynamic improvement after aspiration also does not prove that a purulent collection has been adequately drained.
2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
32.How does an LVAD support circulation, and what changes a low-flow response?
A durable LVAD supports selected patients with advanced HFrEF by moving blood from the left ventricular apex to the aorta. Flow depends on ventricular filling and the pressure opposing pump output. Low-flow alarms can reflect hypovolemia, right ventricular failure, arrhythmia, excessive afterload or obstruction. Assess perfusion, controller and power connections, rhythm and pressure while contacting the LVAD team. Bleeding, infection and pump thrombosis are important complications. [LVAD emergency guideline](https://link.springer.com/article/10.1007/s00134-024-07382-y).
Apply it
A patient has a low-flow alarm, elevated jugular venous pressure and right ventricular dilation. These findings favor impaired delivery of blood to the LVAD from right ventricular failure; an automatic fluid bolus could worsen congestion.
Common pitfall: Continuous flow can produce little palpable pulsatility despite adequate circulation. Absence of a pulse alone does not establish arrest; evaluate responsiveness, breathing, perfusion and device function immediately.
33.How should anti-impulse therapy be sequenced in acute aortic syndrome?
Anti-impulse therapy reduces heart rate and the force of ventricular ejection to limit aortic wall stress. An intravenous beta blocker generally precedes a vasodilator unless contraindicated. Vasodilation before rate control can provoke reflex tachycardia. Targets are heart rate 60–80/min and systolic pressure below 120 mm Hg, or the lowest pressure that preserves organ perfusion. Analgesia and close monitoring accompany definitive aortic management.
Apply it
A patient with acute dissection has heart rate 118/min and systolic pressure 186 mm Hg. Anticipate rate control before adding a vasodilator, with repeated checks of mentation and urine output.
Common pitfall: Pressure reduction without controlling reflex tachycardia can increase aortic stress. Pursuing a numerical target despite worsening organ perfusion also defeats the physiological purpose of treatment.
34.Which medication classes form foundational HFrEF therapy?
Foundational HFrEF therapy combines renin-angiotensin system inhibition, preferably an ARNI when appropriate, an evidence-based beta blocker, an MRA and an SGLT2 inhibitor. These classes improve outcomes through complementary mechanisms. SGLT2 inhibitors benefit eligible HFrEF patients regardless of diabetes status. Diuretics relieve congestion but do not replace the foundational regimen. Selection and titration require review of pressure, renal function, potassium, stability and contraindications.
Apply it
A stable patient takes a loop diuretic and ACE inhibitor but lacks the other foundational classes. Identify opportunities for treatment review rather than interpreting relief of edema as a complete regimen.
Common pitfall: Symptom improvement does not establish complete disease-modifying treatment. Adding a thiazide-type diuretic is reserved for inadequate response to moderate- or high-dose loop therapy because combined nephron blockade increases electrolyte and renal risks.
ACC, AHA, HFSA Issue Heart Failure Guideline · 2022 AHA/ACC/HFSA Heart Failure Guideline Slide Set
35.What safety checks precede switching an ACE inhibitor to an ARNI?
Sacubitril/valsartan combines neprilysin inhibition with angiotensin receptor blockade. Concurrent ACE inhibition increases angioedema risk, requiring at least 36 hours between the last ACE inhibitor dose and ARNI initiation. A history of angioedema is a separate contraindication to ARNI therapy. Assess pressure, renal function, potassium and actual medication administration times. The washout specifically addresses ACE inhibition rather than routine spacing of unrelated medications.
Apply it
A patient is scheduled to start sacubitril/valsartan after receiving lisinopril that morning. Clarify the start time and verify the required interval, then separately review any history of angioedema.
Common pitfall: A low ACE inhibitor dose does not remove the washout requirement. An adequate interval also does not overcome a contraindicating history of angioedema.
36.Which renal and potassium findings permit an MRA in HFrEF?
For appropriate symptomatic HFrEF patients, an MRA is recommended when estimated GFR exceeds 30 mL/min/1.73 m² and potassium is below 5.0 mmol/L. Aldosterone blockade improves outcomes but can cause hyperkalemia, particularly with declining kidney function or other potassium-raising drugs. Recheck potassium and renal function after initiation and dose changes. If potassium cannot be maintained below 5.5 mmol/L, the guideline recommends discontinuing the MRA.
Apply it
A patient has estimated GFR 38 mL/min/1.73 m² and potassium 4.6 mmol/L. These satisfy the laboratory entry criteria, but initiation still needs a plan for follow-up and medication review.
Common pitfall: Qualifying baseline values do not guarantee continuing safety. Potassium supplements, intercurrent AKI and interacting medications can change risk after an initially appropriate prescription.
37.Which beta blockers have established HFrEF outcome benefit?
Carvedilol, sustained-release metoprolol succinate and bisoprolol are supported to reduce mortality and hospitalization in HFrEF. Their long-term benefit reflects modulation of harmful sympathetic activation rather than immediate enhancement of contractility. Initiation and titration require assessment of clinical stability, pressure, heart rate and congestion. Other beta blockers and different formulations should not automatically be treated as interchangeable evidence-based HFrEF therapy.
Apply it
A stable patient takes immediate-release metoprolol tartrate. Identify that sustained-release succinate is the metoprolol formulation with established chronic HFrEF outcome evidence and arrange a deliberate medication review.
Common pitfall: Slowing the pulse does not establish equivalent outcome benefit. Aggressive initiation or escalation during shock can worsen perfusion because beta blockade initially reduces sympathetic support.
38.How do vasopressors and inotropes address different circulatory problems?
Norepinephrine raises vascular tone and pressure and can support a severely hypotensive patient. Persistent low cardiac output with hypoperfusion after filling assessment may require an inotrope such as dobutamine, which increases contractility but can cause tachyarrhythmias and variable blood-pressure effects. Milrinone inhibits phosphodiesterase 3, increasing output while reducing systemic and pulmonary resistance; hypotension and accumulation during renal failure influence selection. Match the drug to pressure, flow and organ perfusion rather than reduced EF alone.
Apply it
After pressure improves with norepinephrine, a patient still has cardiac index 1.6 L/min/m², cold extremities and oliguria despite adequate filling. Anticipate reassessment for inotropic support and track output and perfusion response.
Common pitfall: Higher pressure does not guarantee higher flow. New tachyarrhythmia, ischemia or worsening hypotension should prompt immediate drug and hemodynamic reassessment; an inodilator can worsen profound hypotension.
39.How is DAPT benefit balanced against bleeding after ACS?
DAPT combines aspirin with a P2Y12 inhibitor to reduce recurrent coronary events, particularly after stent placement. The 2025 guideline uses at least 12 months as the default in ACS patients without high bleeding risk, with tailored strategies when risk changes. Treatment duration balances recurrent ischemia and bleeding. Any interruption after PCI requires deliberate review because stopping treatment can remove protection during a vulnerable period.
Apply it
A patient with a recent stent wants to stop the P2Y12 inhibitor because of bruising. Assess bleeding severity, confirm medication use and arrange prompt treatment review before an unsupervised interruption.
Common pitfall: Bruising does not automatically justify stopping DAPT, while serious bleeding cannot be dismissed. Symptom relief after PCI also does not establish that antiplatelet protection is no longer needed.
ACC, AHA Issue New Acute Coronary Syndromes Guideline — 2025
40.How does IABP counterpulsation work, and which findings require action?
An intra-aortic balloon pump inflates at aortic valve closure in diastole to augment diastolic aortic pressure, then deflates before systolic ejection to reduce left ventricular afterload. It can provide selected temporary support for persistent ischemia or circulatory failure while definitive treatment proceeds. Check timing against the arterial waveform and monitor access-site bleeding and distal perfusion. Aortic dissection and moderate or severe aortic regurgitation are contraindications. [AATS IABP teaching resource](https://www.aats.org/tsra-primer-intra-aortic-balloon-pump).
Apply it
During femoral IABP support, the ipsilateral foot becomes cool and its Doppler signal disappears. Treat this as possible device-associated limb ischemia and obtain immediate bedside evaluation.
Common pitfall: Inflation during systole can increase the load against which the ventricle ejects. An augmented pressure waveform does not establish adequate organ perfusion or eliminate the need for definitive coronary or surgical treatment.
41.How are anticoagulant intensity and agent selected for suspected HIT?
Stop heparin for intermediate- or high-probability HIT. High probability requires therapeutic-intensity non-heparin anticoagulation. Intermediate probability permits prophylactic intensity only when bleeding risk is high and no other therapeutic indication exists; a positive immunoassay directs therapeutic intensity. Argatroban or bivalirudin may suit critical illness or possible urgent procedures because their effects are shorter. Avoid argatroban or reduce its dose in moderate or severe hepatic dysfunction. Fondaparinux or a DOAC can suit clinically stable patients at average bleeding risk when renal function and other contraindications permit. [ASH guideline](https://pmc.ncbi.nlm.nih.gov/articles/PMC6258919/).
Apply it
A critically ill patient with likely HIT may need an urgent procedure and has substantial hepatic dysfunction. Bivalirudin offers a short-effect option; renal dysfunction may require dose adjustment and close anticoagulation monitoring.
Common pitfall: Stopping heparin alone leaves thrombotic risk untreated. Avoid early warfarin before platelet recovery and routine platelet transfusion at average bleeding risk; active bleeding can justify transfusion.
ASH-Teaching-Slide-SetVTEHITPDFFINAL71923.pdf · Watermark-ASH_VTE_HIT_PocketGuide.pdf
42.When is synchronized cardioversion appropriate?
A persistent tachyarrhythmia with a pulse causing hypotension, shock, acute altered mental status, ischemic discomfort or acute heart failure generally requires synchronized cardioversion. Synchronization times energy delivery to the QRS and reduces the risk of shocking during vulnerable repolarization. Confirm synchronization markers and provide sedation when feasible without delaying urgent treatment. Sustained polymorphic VT requires unsynchronized shock because reliable synchronization is difficult.
Apply it
A patient has regular monomorphic wide-complex tachycardia with a pulse and new hypotension. Prepare synchronized cardioversion, confirm markers and provide sedation if feasible without prolonging hypoperfusion.
Common pitfall: A pulse does not make every rhythm suitable for synchronized treatment. Polymorphic VT requires a different shock approach, while compensatory sinus tachycardia requires correction of its cause.
AHA Adult Tachyarrhythmia With a Pulse Algorithm — 2025 · AHA 2025 Guidelines, Part 9: Adult Advanced Life Support
43.How is recurrent torsades treated beyond immediate shock?
After immediate electrical treatment when necessary, address the prolonged-QT substrate. Remove QT-prolonging drugs, correct potassium and magnesium abnormalities and consider magnesium therapy. For acquired long-QT torsades triggered by pauses, increasing heart rate through pacing or selected chronotropic treatment can help prevent recurrence under expert direction. These measures differ from treatment of polymorphic VT with normal preceding QT, where acute ischemia may be central.
Apply it
After torsades terminates, telemetry shows bradycardia and pauses and medication review identifies a QT-prolonging drug. Anticipate withdrawal of the contributor, electrolyte correction and consideration of rate support.
Common pitfall: Repeated shocks terminate episodes without necessarily preventing recurrence. Medications that further prolong QT can worsen this substrate even when useful for other ventricular arrhythmias.
44.When does unstable bradycardia require pacing support?
Bradycardia requires urgent treatment when it causes hypotension, altered mentation, ischemic discomfort or acute heart failure. Address reversible causes while following the bradycardia treatment pathway. Persistent instability despite medical treatment can require transcutaneous pacing as a bridge and temporary transvenous pacing. Confirm electrical capture and a corresponding mechanical response because monitor appearance alone does not prove that tissue perfusion has improved.
Apply it
A patient with advanced AV block remains hypotensive despite initial medication treatment. Prepare pacing support and, once pacing begins, confirm a matching pulse and improved perfusion rather than relying only on visible pacing spikes.
Common pitfall: Electrical capture without mechanical output does not resolve shock. Delaying pacing preparation until profound deterioration can waste time in persistent symptomatic conduction disease.
45.Which HFrEF pattern has a strong CRT indication?
A strong CRT indication includes LVEF at most 35%, sinus rhythm, LBBB, QRS duration at least 150 milliseconds and NYHA class II, III or ambulatory IV symptoms on guideline-directed therapy. CRT improves coordination when ventricular electrical activation is markedly delayed. Benefit depends on the electrical pattern, symptoms and function rather than ejection fraction alone. Comorbidities limiting survival with good functional capacity to less than one year preclude ICD or CRT-defibrillator implantation.
Apply it
A patient has NYHA class III symptoms, LVEF 28%, sinus rhythm and LBBB measuring 166 milliseconds despite treatment. Recognize strong grounds for CRT evaluation.
Common pitfall: A narrow QRS does not provide the same resynchronization target. CRT's coordination benefit also differs from an ICD's role in terminating dangerous ventricular arrhythmias.
46.What defines a principal primary-prevention ICD pathway?
For nonischemic dilated cardiomyopathy or ischemic heart disease, a principal indication includes LVEF at most 35%, NYHA class II–III symptoms on chronic guideline-directed therapy and expected meaningful survival beyond one year. Prior-MI patients must be at least 40 days beyond infarction. A separate post-MI pathway covers NYHA class I patients with LVEF at most 30%, the same waiting period and appropriate therapy and survival expectation.
Apply it
Five months after MI, a patient has LVEF 28% and NYHA class II symptoms despite chronic treatment. Recognize the primary-prevention ICD pathway and separately assess CRT criteria.
Common pitfall: An early post-MI low EF does not remove the waiting period. NYHA class I with EF 33% also does not satisfy the separate post-MI class I pathway.
47.How is palliative care integrated into heart failure management?
Palliative and supportive care includes symptom relief, communication about prognosis, eliciting goals and supporting patients and caregivers throughout heart failure care. Specialist consultation can assist with refractory symptoms and major advanced-therapy decisions. Discuss possible future discontinuation of life-extending treatments when they begin and revisit preferences as illness changes. Decisions about ICD shocks, resuscitation and other interventions should address each treatment's benefits and burdens.
Apply it
A patient with advanced HF reports distress from recurrent ICD shocks. Clarify goals, explain treatment options and arrange a specific device discussion while continuing symptom management.
Common pitfall: Do not postpone conversations until crisis. Accepting palliative support does not automatically determine every device or resuscitation decision; each requires an informed discussion consistent with the patient's goals.
48.How are ventilation and positioning used to limit injury in ARDS?
ARDS ventilation uses tidal volumes of 4–8 mL/kg predicted body weight and plateau pressure below 30 cm H2O. Predicted weight reflects height and sex-based estimates of lung size rather than actual mass; approximately 6 mL/kg is a common starting volume. Severe ARDS supports prone positioning for more than 12 hours daily with coordinated airway, line and pressure-area care. Prolonged lung recruitment maneuvers are discouraged because oxygenation improvement alone does not establish net benefit.
Apply it
A patient with predicted body weight 60 kg receives 600-mL breaths. Recognize 10 mL/kg, anticipate reduction toward a protective range and reassess plateau pressure and gas exchange. Persistent severe hypoxemia warrants assessment for prolonged prone positioning.
Common pitfall: Actual weight overestimates suitable tidal volume in obesity. Peak pressure cannot substitute for plateau pressure, and transient oxygenation improvement does not rule out pressure injury or circulatory harm.
ATS/ESICM/SCCM Mechanical Ventilation in Adult ARDS Guideline — 2017 · ATS 2024 Clinical Year in Review
49.When does noninvasive ventilation help cardiogenic pulmonary edema?
CPAP or bilevel noninvasive ventilation can improve acute cardiogenic pulmonary edema by recruiting alveoli and reducing respiratory effort; positive intrathoracic pressure can also reduce left ventricular afterload. Use requires close reassessment of oxygenation, ventilation, consciousness and blood pressure. Positive pressure can reduce venous return and worsen hypotension. Inability to protect the airway, progressive exhaustion or deterioration requires prompt invasive-airway assessment. [ERS/ATS NIV guideline](https://www.thoracic.org/statements/resources/cc/niv-guidelines.pdf).
Apply it
An alert patient with hypertensive pulmonary edema has severe work of breathing and hypoxemia. Anticipate NIV alongside cardiac treatment. Falling pressure or worsening alertness changes the plan and requires immediate reassessment.
Common pitfall: A better saturation does not establish that ventilatory failure has resolved. Do not prolong an unsuccessful NIV trial while acidosis, exhaustion or impaired airway protection worsens.
50.Which AKI complications require urgent renal replacement therapy?
KDIGO recommends emergency renal replacement therapy for life-threatening fluid, electrolyte or acid-base disturbances. Examples include refractory hyperkalemia, severe refractory acidosis and pulmonary edema not controlled medically. Decisions depend on clinical context and trends rather than an isolated creatinine or urea threshold. Continuous treatment may be preferred over standard intermittent treatment in hemodynamically unstable patients because fluid and solute removal occur more gradually.
Apply it
A patient has persistent severe hyperkalemia and pulmonary edema despite appropriate treatment, with unstable blood pressure. Anticipate urgent renal replacement therapy and consideration of a continuous modality.
Common pitfall: Creatinine alone is not an emergency dialysis trigger. Conversely, dangerous complications justify urgent treatment even when creatinine appears less dramatic than expected.
KDIGO Clinical Practice Guideline for Acute Kidney Injury — 2012
51.How is temperature managed after adult cardiac arrest?
Adults unresponsive to verbal commands after ROSC should receive deliberate protocolized temperature control within 32–37.5°C, irrespective of presenting rhythm or arrest location. Maintaining control for at least 36 hours is reasonable. Prevent uncontrolled fever and use a measured core temperature to guide treatment. Hypothermic strategies require surveillance for shivering, arrhythmias and electrolyte changes; rewarming should be controlled, with avoidance of rates faster than 0.5°C/hour considered reasonable. [2025 AHA post-arrest guideline](https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines/post-cardiac-arrest-care).
Apply it
An adult remains unresponsive after ROSC and core temperature rises above the prescribed target. Check the temperature probe and delivery system, assess shivering and implement the temperature-control protocol while monitoring circulation and electrolytes.
Common pitfall: Temperature control includes active fever prevention; it does not require every patient to reach 33°C. Sedation and temperature treatment can confound the neurological examination, so an early examination alone should not determine prognosis.
Monitoring and Diagnostics16%
52.How should serial troponin results be interpreted?
Interpret troponin against the assay's sex-specific 99th-percentile upper reference limit, sampling interval and presentation. A rise or fall supports acute injury; ischemic evidence determines whether that injury represents infarction. A pooled threshold can miss injury in women when it exceeds the assay's female limit. Kidney disease can cause chronic elevation but does not make a new dynamic change irrelevant. [AHA definition summary](https://professional.heart.org/en/science-news/fifth-universal-definition-of-myocardial-infarction-2026/top-things-to-know).
Apply it
A woman with CKD develops chest discomfort and a clear troponin rise above the assay's female reference limit. Evaluate ischemia rather than dismissing the result because it remains below a pooled limit or because CKD is present.
Common pitfall: Another assay's cutoff or a universal numerical delta can misclassify injury. Stable and changing elevations require different interpretation, and neither pattern alone identifies coronary thrombosis.
53.Which echocardiographic findings support tamponade physiology?
Echocardiography assesses effusion size and distribution, right-sided chamber collapse, venous congestion and respiratory variation in filling. Right atrial or right ventricular collapse can support tamponade, but expected signs depend on chamber pressures and clinical context. Elevated right-sided pressures can alter the pattern. The decisive interpretation combines imaging with symptoms, blood pressure and evidence of impaired perfusion to determine whether drainage is urgent.
Apply it
A patient with an effusion develops hypotension and right ventricular diastolic collapse. Integrate imaging and deterioration to support urgent management rather than reporting effusion dimensions alone.
Common pitfall: An effusion is not synonymous with tamponade. Absence of one classic echocardiographic sign also does not safely exclude clinically important tamponade when the remaining physiology is concerning.
2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
54.How does mixed venous oxygen saturation clarify oxygen-delivery failure?
Mixed venous oxygen saturation, sampled from the pulmonary artery, reflects the balance among arterial saturation, hemoglobin, cardiac output and oxygen consumption. A low value can indicate increased extraction caused by inadequate delivery or increased demand. Interpret it with flow, lactate and examination findings. Central venous saturation is sampled from a different location and is not numerically interchangeable. [ESICM shock-monitoring consensus](https://pmc.ncbi.nlm.nih.gov/articles/PMC4239778/).
Apply it
SaO2 is 98%, SvO2 is 48%, hemoglobin is 10 g/dL and cardiac index is 1.6 L/min/m² with cold extremities and oliguria. Approximate extraction is (98−48)/98, or 51%, ignoring dissolved oxygen. The combination supports inadequate delivery from low flow despite good arterial saturation.
Common pitfall: Do not increase oxygen solely to normalize SvO2 when arterial saturation is already adequate. Assess flow, anemia and demand; normal or high venous saturation can coexist with impaired tissue extraction.
55.How does ABI interpretation change when arteries are noncompressible?
Resting ABI is abnormal at 0.90 or less, borderline at 0.91–0.99, normal at 1.00–1.40 and noncompressible above 1.40. A high ratio can reflect stiff arteries rather than excellent perfusion, particularly in diabetes or kidney disease. When PAD is suspected with noncompressible ABI, toe pressure or toe-brachial testing with waveforms is recommended. Symptoms and arterial compressibility therefore determine whether the measurement answers the clinical question.
Apply it
A patient with diabetes has exertional calf discomfort and ABI 1.52. Recognize noncompressibility and anticipate toe-brachial testing with waveforms rather than offering reassurance from the high ratio.
Common pitfall: Higher is not always better for ABI. Calling every result above 1.00 normal overlooks the noncompressible category and can delay PAD evaluation.
56.How do filling pressure and flow together guide a hemodynamic assessment?
Selected patients with worsening heart failure and uncertain hemodynamics can benefit from invasive assessment. Filling pressures describe congestion; cardiac output or cardiac index describes flow. High pressure can coexist with inadequate output. Verify leveling, zeroing and waveform quality before acting, then integrate measurements with perfusion and treatment response. A static filling pressure alone does not establish fluid responsiveness. [ESICM shock-monitoring consensus](https://pmc.ncbi.nlm.nih.gov/articles/PMC4239778/).
Apply it
Right atrial pressure is 16 mm Hg, pulmonary artery occlusion pressure 28 mm Hg and cardiac index 1.6 L/min/m², with pulmonary edema and oliguria. This is a congested low-flow pattern. An automatic fluid bolus risks worsening congestion; reassess ventricular function, pressure support and inotropic needs.
Common pitfall: A mean arterial pressure of 70 mm Hg does not negate low flow. Repeat pressure, output, lactate and bedside perfusion assessment after treatment rather than targeting one catheter value.
57.Why can pulse oximetry disagree with the clinical picture?
Pulse oximetry estimates arterial oxygen saturation. Accuracy can be affected by poor circulation, skin pigmentation, skin temperature, skin thickness, tobacco use and nail polish. Motion and signal quality also affect bedside interpretation. Assess symptoms, waveform and perfusion alongside the number. A reassuring saturation does not measure ventilation, hemoglobin concentration or total oxygen delivery, so clinically important respiratory or circulatory problems can remain present.
Apply it
A patient has cool fingers, an inconsistent signal and visible respiratory distress despite a displayed saturation of 96%. Reassess the probe and patient and obtain appropriate confirmatory testing when indicated.
Common pitfall: A plausible displayed number can still be inaccurate. Normal saturation also cannot exclude hypercapnia or anemia because neither is measured by the saturation value.
58.How do ABGs distinguish oxygenation from ventilation?
Arterial oxygen tension assesses oxygenation, while arterial carbon dioxide tension reflects ventilation relative to carbon dioxide production. Interpret pH and bicarbonate with carbon dioxide to distinguish respiratory disorders from metabolic processes and compensation. The PaO2/FiO2 ratio relates oxygen tension to the inspired oxygen fraction. A satisfactory saturation on supplemental oxygen does not establish adequate ventilation or exclude respiratory acidosis.
Apply it
A patient has PaO2 72 mm Hg on FiO2 0.60, giving a ratio of 120. Assess PaCO2 and pH separately because the oxygenation ratio cannot determine whether ventilation is adequate.
Common pitfall: Use 0.60 rather than 60 for FiO2 in the calculation. Treating saturation as a substitute for carbon dioxide assessment can also miss progressive ventilatory failure.
ATS/ESICM/SCCM Mechanical Ventilation in Adult ARDS Guideline — 2017
59.What can waveform capnography reveal during resuscitation?
Waveform capnography helps confirm and monitor tracheal tube placement and provides information about ventilation and pulmonary blood flow during CPR. A sudden sustained rise in end-tidal carbon dioxide can suggest return of spontaneous circulation. Values also depend on ventilation and metabolism, so an isolated low result has several possible explanations. Capnography should not independently determine when resuscitation efforts stop.
Apply it
With ventilation unchanged, end-tidal carbon dioxide suddenly rises and remains elevated during CPR. Consider ROSC and coordinate an appropriate assessment without an unplanned prolonged interruption of compressions.
Common pitfall: A rise is a cue for assessment rather than proof of ROSC. One low value is also not a stand-alone termination criterion, and equipment or ventilation changes can alter readings.
60.How should remote pulmonary artery pressure trends guide assessment?
Remote pulmonary artery pressure monitoring supplies longitudinal congestion information in selected heart failure patients. Trends can change before obvious symptoms, but interpretation requires an individualized baseline, symptom review, medication history and renal and electrolyte assessment. A transmitted pressure is a physiological signal rather than a complete treatment instruction. Guideline discussion recognizes uncertainty about usefulness in selected populations, so monitoring should not be presented as universally necessary or beneficial.
Apply it
A patient's transmitted pressures rise over several days while weight changes little. Review symptoms, medication use and contributors and communicate the trend for individualized management.
Common pitfall: One abnormal transmission should not automatically trigger a large diuretic adjustment. Remote measurements complement clinical assessment, and benefit depends on appropriate selection and a responsive management program.
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Interpret myocardial injury using assay-specific, sex-specific limits, serial biomarkers and evidence of ischemia.
- Recognize tamponade, acute regurgitation, hypertensive organ injury, dangerous syncope, aortic malperfusion and threatened limbs.
- Apply ARNI washout, MRA laboratory limits, DAPT precautions and probability-based HIT treatment and agent selection.
- Connect cardiac disease with respiratory failure, stroke, withdrawal, hyperglycemic crises, anemia and kidney injury.
- Explain IABP timing, LVAD flow dependence, vasoactive selection, NIV failure and post-arrest temperature control.
- Interpret pressure versus flow, arterial versus mixed venous oxygen assessment, and electrical capture versus mechanical output.
A practical preparation plan
1. Start with the complete official outline
Identify topics beyond this selective guide and distribute study time approximately by the applicable published domain weights.
2. Compare mechanisms
Explain injury versus infarction, congestion versus hypoperfusion, DKA versus HHS, and synchronized versus unsynchronized shock. Identify the finding that changes the decision.
3. Rehearse treatment boundaries
For each intervention, state its purpose, eligibility criteria, contraindications and monitoring needs. Connect the expected benefit with the mechanism being treated.
4. Calculate and interpret
Practise urine output per kilogram per hour, predicted-body-weight tidal volumes, PaO2/FiO2 ratios and oxygen extraction. Interpret filling pressures with flow and explain what each result establishes.
5. Explain every alternative
Answer the practice cases, then explain why each alternative is less appropriate. Use the rationales and flashcards to revisit missed mechanisms and safety boundaries.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- CMC Certification — AACN
- CMC Exam Handbook — August 2026
- Fifth Universal Definition of Myocardial Infarction — 2026
- ACC, AHA, HFSA Issue Heart Failure Guideline
- 2022 AHA/ACC/HFSA Heart Failure Guideline Slide Set
- 2022 ACC/AHA Aortic Disease Guideline Slide Set
- 2022 ACC/AHA Aortic Disease Guideline Key Perspectives: Part 2
- 2024 AHA/ACC Peripheral Artery Disease Guideline Slide Set
- Hyperglycaemic Crises in Adults With Diabetes: A Consensus Report — 2024
- ASH Diagnosis and Management of Heparin-Induced Thrombocytopenia
- ASH Choosing Wisely Recommendations
- KDIGO Clinical Practice Guideline for Acute Kidney Injury — 2012
- KDIGO Acute Kidney Injury and Acute Kidney Disease
- ATS/ESICM/SCCM Mechanical Ventilation in Adult ARDS Guideline — 2017
- ATS 2024 Clinical Year in Review
- AHA Adult Tachyarrhythmia With a Pulse Algorithm — 2025
- AHA 2025 Guidelines, Part 9: Adult Advanced Life Support
- FDA Pulse Oximeters
- ACC, AHA Issue New Acute Coronary Syndromes Guideline — 2025
- 2025 ESC Guidelines for the Management of Myocarditis and Pericarditis
- Hyperglycemic-Crises-in-Adults-With-Diabetes-A-Consensus-Report.pdf
- ASH VTE Guidelines: Heparin-Induced Thrombocytopenia (HIT) - Hematology.org
- ASH-Teaching-Slide-SetVTEHITPDFFINAL71923.pdf
- Watermark-ASH_VTE_HIT_PocketGuide.pdf
- KDIGO-Acute-Hyperkalemia-conf-report-FINAL.pdf
- cmcexamhandbook.pdf
- the_asam_clinical_practice_guideline_on_alcohol-1.pdf
- Client Challenge
- Intra-aortic… | The American Association for Thoracic Surgery | AATS
- niv-guidelines.pdf
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.